tirzepatide comprimido (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects Tirzepatide Oral | Starts at

This progressive overload signals your muscles to maintain or build strength even while you lose weight

Despite their similar appearances, all three require different types of maintenance

Currently, Wegovy is FDA approved for the following: Children ages 12 years or older with a body mass index (BMI) at or above the 95th percentile for their sex and age Adults with a BMI at or above 30 Adults with a BMI at or above 27 and at least one weight-related health condition, such as heart disease, diabetes, high blood pressure, or sleep apnea Adults with a BMI at or above 27 with established cardiovascular disease and a risk of major adverse cardiovascular events (like heart attack or stroke) Adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis Note that there are slightly different prescribing rules for Wegovy pills versus Wegovy injections

However, one study has shown that people regain about two-thirds of the weight they lost after stopping the medication

Goodman and Gilman's The Pharmacological Basis of Therapeutics

Using genetic and biomarker insights to guide maintenance decisions can help you and your provider move beyond one-size-fits-all protocols toward a truly personalized approach